These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2884849)

  • 1. Mechanism of alpha blockade for blood pressure control.
    Davey M
    Am J Cardiol; 1987 May; 59(14):18G-28G. PubMed ID: 2884849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.
    Davey MJ
    Am J Med; 1989 Aug; 87(2A):36S-44S. PubMed ID: 2569823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.
    Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA; Reid JL; Vincent J
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system in essential hypertension and antihypertensive response to alpha 2-adrenoceptor stimulation.
    Bühler FR; Bolli P; Amann WF; Erne P; Kiowski W
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S753-6. PubMed ID: 6084119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL; Vincent J
    Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
    Graham RM
    Am J Cardiol; 1984 Jan; 53(3):16A-20A. PubMed ID: 6141721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH
    Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
    Dunn WR; McGrath JC; Wilson VG
    Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.
    Alabaster VA; Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):9S-17S. PubMed ID: 2871857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension.
    Wilner KD; Ziegler MG
    Am J Cardiol; 1987 May; 59(14):82G-86G. PubMed ID: 2884858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha adrenoceptors--an overview.
    Davey MJ
    J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():1-15. PubMed ID: 2879937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.
    González-Juanatey JR; Iglesias MJ; Alcaide C; Piñeiro R; Lago F
    Circulation; 2003 Jan; 107(1):127-31. PubMed ID: 12515754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin.
    Downing OA; Wilson KA; Wilson VG
    Br J Pharmacol; 1983 Oct; 80(2):315-22. PubMed ID: 6140057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
    Elliott HL; Meredith PA; Sumner DJ; McLean K; Reid JL
    Br J Clin Pharmacol; 1982 May; 13(5):699-703. PubMed ID: 6123342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.